Literature DB >> 3312038

[Rational parameters in the treatment of bacterial meningitis with modern cephalosporins].

O Brückner1, M Trautmann.   

Abstract

Modern cephalosporins are by now well established therapeutic drugs in the treatment of bacterial meningitis. Particularly for gram-negative meningitis they are valuable therapeutic tools. In most cases, they are very efficient and less toxic than former therapeutic regimens. Of course, they cannot replace penicillin G in the therapy of meningitis with penicillin-sensitive bacteria. The advantages and disadvantages of the single compounds, cefotaxime, latamoxef, ceftizoxime, cefmenoxime, ceftazidime, ceftriaxone and cefsulodin have to be evaluated. For safety reasons, monotherapy with these drugs is not recommended because there have been reports of failures and relapses of meningitis even in cases with highly sensitive organisms. They are almost or completely ineffective against a few pathogens in meningitis, such as anaerobes or Listeria monocytogenes. An attempt has been made to evaluate the different compounds for their therapeutic usefulness against different pathogens in meningitis.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3312038     DOI: 10.1007/BF01645874

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  41 in total

1.  [Blood and cerebrospinal fluid levels during therapy of bacterial meningitis with high doses of penicillin G and ampicillin (author's transl)].

Authors:  W Auwärter; H Maurer; H Förtner
Journal:  Infection       Date:  1973       Impact factor: 3.553

2.  Good antimicrobial prescribing. Clinical uses of cephalosporins.

Authors:  H C Neu
Journal:  Lancet       Date:  1982-07-31       Impact factor: 79.321

Review 3.  Cephalosporins in adult meningitis.

Authors:  T R Beam
Journal:  Bull N Y Acad Med       Date:  1984-05

4.  Successful treatment of Pseudomonas aeruginosa meningitis with ceftazidime.

Authors:  T S Elliott; P Ispahani; B P Choudhary
Journal:  J Infect       Date:  1983-11       Impact factor: 6.072

5.  Comparison of ceftriaxone with standard therapy for bacterial meningitis.

Authors:  R W Steele; R W Bradsher
Journal:  J Pediatr       Date:  1983-07       Impact factor: 4.406

6.  Comparison of ceftriaxone and traditional therapy of bacterial meningitis.

Authors:  B L Congeni
Journal:  Antimicrob Agents Chemother       Date:  1984-01       Impact factor: 5.191

7.  Treatment of bacterial meningitis with ceftizoxime.

Authors:  G D Overturf; D C Cable; D N Forthal; C Shikuma
Journal:  Antimicrob Agents Chemother       Date:  1984-02       Impact factor: 5.191

8.  [Cefsulodin in the treatment of Pseudomonas meningitis].

Authors:  O Brückner; H Collmann; M Trautmann
Journal:  Infection       Date:  1983 Sep-Oct       Impact factor: 3.553

9.  Comparative in vitro study in new cephalosporins.

Authors:  G P Bodey; V Fainstein; A M Hinkle
Journal:  Antimicrob Agents Chemother       Date:  1981-08       Impact factor: 5.191

10.  Examination of gram-negative bacilli from meningitis patients who failed or relapsed on moxalactam therapy.

Authors:  R H Eng; C Cherubin; S M Smith; F Buccini
Journal:  Antimicrob Agents Chemother       Date:  1984-12       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.